Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort.

ABSTRACT:

Background and objective

The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive pulmonary disease (COPD). Their systematic identification and relationship with all-cause mortality have not been explored. Furthermore, whether their CT-detected prevalence differs from clinical diagnosis is unknown.

Methods

The prevalence of 10 CT-assessed comorbidities was retrospectively determined at baseline in 379 patients (71% men) with mild to severe COPD attending pulmonary clinics. Anthropometrics, smoking history, dyspnoea, lung function, exercise capacity, BODE (BMI, Obstruction, Dyspnoea and Exercise capacity) index and exacerbations rate were recorded. The prevalence of CT-determined comorbidities was compared

SUBMITTER: Ezponda A 

PROVIDER: S-EPMC9303420 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature